Your session is about to expire
← Back to Search
Aerobic Exercise for Parkinson's Disease (LTAE-PD Trial)
LTAE-PD Trial Summary
This trial will test the long term effects of aerobic exercise on the brain tissue, movement, mental functions, and driving in Parkinson's Disease patients.
LTAE-PD Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowLTAE-PD Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.LTAE-PD Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I do not have any severe or unstable health conditions.My Parkinson's is at an early to mid-stage, and I've been on stable Parkinson's medication for over 4 weeks.You don't have severe memory or thinking problems according to specific guidelines.I haven't taken antipsychotic or dopamine blocking drugs in the last 6 months.My Parkinson's symptoms are caused by medication.I have had brain surgery for Parkinson's disease.I am 40 or older and have been diagnosed with Parkinson's disease.You have health conditions that make it unsafe for you to participate in exercise, according to the American College of Sports Medicine guidelines.Your vision is not clear enough (worse than 20/50) to drive safely.I have been diagnosed with a Parkinson-plus syndrome.You have been diagnosed with dementia according to specific criteria.I have a valid driver's license and am currently driving.My aerobic fitness level is not considered 'very good' for my age and gender.You cannot have a brain MRI for medical reasons.You do not have dementia according to specific criteria from the Movement Disorder Society.You have severe depression based on a test score called the Beck Depression Inventory (BDI).I have been on a stable dose of my brain-related medication for at least 30 days.My aerobic fitness level is not considered 'very good' for my age and gender.You have a serious head injury or post-traumatic stress disorder (PTSD).
- Group 1: Control
- Group 2: Aerobic
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Are people with the required medical history still able to sign up for this research program?
"Correct, this research is ongoing and is recruiting participants, as stated on the clinicaltrials.gov website. The listing for this trial was first posted on 7/1/2019, and the most recent update was on 8/26/2022."
Why was this research project undertaken?
"The aim of this study, as evaluated by the change in Baseline Percent Increase Score (PIS) on Eriksen's flanker task over the course of a year, is to improve regional DTI. Additionally, this study will also monitor changes in motor function, ability to complete activities of daily living, and cognitive and memory skills."
Who else is applying?
What state do they live in?
How old are they?
What portion of applicants met pre-screening criteria?
Share this study with friends
Copy Link
Messenger